APRIL promotes proliferation, secretion and invasion of fibroblast-like synoviocyte from rats with adjuvant induced arthritis

Molecular Immunology

Volumn 64, Issue 1, 2015, Pages 90-98

  Chang, Yan ^a   Jia, Xiaoyi ^a   Sun, Xiaojing ^a   Xu, Shu ^a   Wu, Yujing ^a   Zhang, Lingling ^a   Wei, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Adjuvant induced arthritis; APRIL; Fibroblast like synoviocyte; Rheumatoid arthritis; TACI Ig

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR RECEPTOR; B CELL MATURATION ANTIGEN; GELATINASE B; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; AUTACOID;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL INVASION; CELL PROLIFERATION; CELLULAR SECRETION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIOCYTE; T LYMPHOCYTE; ANIMAL; CELL MOTION; DRUG EFFECTS; ENZYMOLOGY; EXPERIMENTAL ARTHRITIS; FIBROBLAST; GENETICS; METABOLISM; PATHOLOGY; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; SYNOVIUM;

ANIMALIA; RATTUS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; B-CELL ACTIVATION FACTOR RECEPTOR; B-CELL MATURATION ANTIGEN; CELL MOVEMENT; CELL PROLIFERATION; FIBROBLASTS; INFLAMMATION MEDIATORS; MALE; MATRIX METALLOPROTEINASE 9; RATS, SPRAGUE-DAWLEY; SYNOVIAL MEMBRANE; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84920075583     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.11.002     Document Type: Article

References (45)

1. Bossen C., Schneider P. BAFF, APRIL and their receptors: structure, function and signalling. Semin. Immunol. 2006, 18:263-275.
2. Bottini N., Firestein G.S. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat. Rev. Rheumatol. 2013, 9:24-33.
3. Castigli E., Scott S., Dedeoglu F., Bryce P., Jabara H., Bhan A.K., Mizoguchi E., Geha R.S. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3903-3908.
4. Castigli E., Wilson S.A., Scott S., Dedeoglu F., Xu S., Lam K.P., Bram R.J., Jabara H., Geha R.S. TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 2005, 201:35-39.
5. Chang Y., Wu Y., Wang D., Wei W., Qin Q., Xie G., Zhang L., Yan S., Chen J., Wang Q., Wu H., Xiao F., Sun W., Jin J., Wang W. Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses. Rheumatology (Oxford) 2011, 50:862-870.
6. Cooles F.A., Isaacs J.D. Pathophysiology of rheumatoid arthritis. Curr. Opin. Rheumatol. 2011, 23:233-240.
7. Chu V.T., Enghard P., Riemekasten G., Berek C. In vitro and in vivo activation induces BAFF and APRIL expression in B cells. J. Immunol. 2007, 179:5947-5957.
8. Dillon S.R., Gross J.A., Ansell S.M., Novak A.J. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat. Rev. Drug. Discov. 2006, 5:235-246.
9. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 1996, 14:397-440.
10. Feldmann M., Maini S.R. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol. Rev. 2008, 223:7-19.
11. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
12. Hahne M., Kataoka T., Schröter M., Hofmann K., Irmler M., Bodmer J.L., Schneider P., Bornand T., Holler N., French L.E., Sordat B., Rimoldi D., Tschopp J. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 1998, 188:1185-1190.
13. Haringman J.J., Smeets T.J., Reinders-Blankert P., Tak P.P. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann. Rheum. Dis. 2006, 65:294-300.
14. He B., Xu W., Santini P.A., Polydorides A.D., Chiu A., Estrella J., Shan M., Chadburn A., Villanacci V., Plebani A., Knowles D.M., Rescigno M., Cerutti A. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 2007, 26:812-826.
15. Juarranz M.G., Santiago B., Torroba M., Gutierrez-Cañas I., Palao G., Galindo M., Abad C., Martinez C., Leceta J., Pablos J.L., Gomariz R.P. Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells. Rheumatology (Oxford) 2004, 43:416-422.
16. Kelly K., Manos E., Jensen G., Nadauld L., Jones D.A. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 2000, 60:1021-1027.
17. Koyama T., Tsukamoto H., Miyagi Y., Himeji D., Otsuka J., Miyagawa H., Harada M., Horiuchi T. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2005, 64:1065-1067.
18. Lam Q.L., Zheng B.J., Jin D.Y., Cao X., Lu L. Leptin induces CD40 expression through the activation of Akt in murine dendritic cells. J. Biol. Chem. 2007, 282:27587-27597.
19. Lefèvre S., Knedla A., Tennie C., Kampmann A., Wunrau C., Dinser R., Korb A., Schnäker E.M., Tarner I.H., Robbins P.D., Evans C.H., Stürz H., Steinmeyer J., Gay S., Schölmerich J., Pap T., Müller-Ladner U., Neumann E. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat. Med. 2009, 15:1414-1420.
20. Mackay F., Leung H. The role of the BAFF/APRIL system on T cell function. Semin. Immunol. 2006, 18:284-289.
21. Mackay F., Schneider P., Rennert P., Browning J. BAFF and APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 2003, 21:231-264.
22. Mackay F., Sierro F., Grey S.T., Gordon T.P. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr. Dir. Autoimmun. 2005, 8:243-265.
23. Madhok R., Crilly A., Watson J., Capell H.A. Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann. Rheum. Dis 1993, 52:232-234.
24. Moreaux J., Legouffe E., Jourdan E., Quittet P., Rème T., Lugagne C., Moine P., Rossi J.F., Klein B., Tarte K. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004, 103:3148-3157.
25. Müller-Ladner U., Pap T., Gay R.E., Neidhart M., Gay S. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 2005, 1:102-110.
26. Nagatani K., Itoh K., Nakajima K., Kuroki H., Katsuragawa Y., Mochizuki M., Aotsuka S., Mimori A. Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL. Arthritis Rheum. 2007, 56:3554-3563.
27. Ng L.G., Sutherland A.P., Newton R., Qian F., Cachero T.G., Scott M.L., Thompson J.S., Wheway J., Chtanova T., Groom J., Sutton I.J., Xin C., Tangye S.G., Kalled S.L., Mackay F., Mackay C.R. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol. 2004, 173:807-817.
28. O'Connor B.P., Raman V.S., Erickson L.D., Cook W.J., Weaver L.K., Ahonen C., Lin L.L., Mantchev G.T., Bram R.J., Noelle R.J. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 2004, 199:91-98.
29. Ohata J., Zvaifler N.J., Nishio M., Boyle D.L., Kalled S.L., Carson D.A., Kipps T.J. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J. Immunol. 2005, 174:864-870.
30. Parks W.C., Wilson C.L., Lopez-Boado Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 2004, 4:617-629.
31. Qin Q., Chang Y., Wang D., Wu Y., Zhang L.L., Wei W. TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis. Int. Immunopharmacol. 2011, 11:2167-2175.
32. Rennert P., Schneider P., Cachero T.G., Thompson J., Trabach L., Hertig S., Holler N., Qian F., Mullen C., Strauch K., Browning J.L., Ambrose C., Tschopp J.A. Soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J. Exp. Med. 2000, 192:1677-1684.
33. Roschke V., Sosnovtseva S., Ward C.D., Hong J.S., Smith R., Albert V., Stohl W., Baker K.P., Ullrich S., Nardelli B., Hilbert D.M., Migone T.S. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. J. Immunol. 2002, 169:4314-4321.
34. Seyler T.M., Park Y.W., Takemura S., Bram R.J., Kurtin P.J., Goronzy J.J., Weyand C.M. BLyS and APRIL in rheumatoid arthritis. J. Clin. Invest. 2005, 115:3083-3092.
35. Stein J.V., López-Fraga M., Elustondo F.A., Carvalho-Pinto C.E., Rodríguez D., Gómez-Caro R., De Jong J., Martínez-A C., Medema J.P., Hahne M. APRIL modulates B and T cell immunity. J. Clin. Invest. 2002, 109:1587-1598.
36. Tan S.M., Xu D., Roschke V., Perry J.W., Arkfeld D.G., Ehresmann G.R., Migone T.S., Hilbert D.M., Stohl W. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 2003, 48:982-992.
37. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., Hession C., Schneider P., Sizing I.D., Mullen C., Strauch K., Zafari M., Benjamin C.D., Tschopp J., Browning J.L., Ambrose C. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001, 293:2108-2111.
38. Tolboom T.C., Pieterman E., van der Laan W.H., Toes R.E., Huidekoper A.L., Nelissen R.G., Breedveld F.C., Huizinga T.W. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann. Rheum. Dis. 2002, 61:975-980.
39. Vallerskog T., Heimbürger M., Gunnarsson I., Zhou W., Wahren-Herlenius M., Trollmo C., Malmström V. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res. Ther. 2006, 8:R167.
40. Varfolomeev E., Kischkel F., Martin F., Seshasayee D., Wang H., Lawrence D., Olsson C., Tom L., Erickson S., French D., Schow P., Grewal I.S., Ashkenazi A. APRIL-deficient mice have normal immune system development. Mol. Cell. Biol. 2004, 24:997-1006.
41. Von Bülow G.U., Bram R.J. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 1997, 278:138-141.
42. Vosters J.L., Roescher N., Polling E.J., Illei G.G., Tak P.P. The expression of APRIL in Sjogren's syndrome: aberrant expression of APRIL in the salivary gland. Rheumatology (Oxford) 2012, 51:1557-1562.
43. Wang D., Chang Y., Wu Y., Zhang L., Yan S., Xie G., Qin Q., Jin J., Wang W., Fang J., Wei W. Therapeutic effects of TACI-Ig on rat with adjuvant arthritis. Clin. Exp. Immunol. 2011, 163:225-234.
44. Wang H., Marsters S.A., Baker T., Chan B., Lee W.P., Fu L., Tumas D., Yan M., Dixit V.M., Ashkenazi A., Grewal I.S. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat. Immunol. 2001, 2:632-637.
45. Yu G., Boone T., Delaney J., Hawkins N., Kelley M., Ramakrishnan M., McCabe S., Qiu W.R., Kornuc M., Xia X.Z., Guo J., Stolina M., Boyle W.J., Sarosi I., Hsu H., Senaldi G., Theill L.E. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat. Immunol. 2000, 1:252-256.